People · Operator
Named in public records as an officer, director or promoter · active 2009–2025 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| AltheaDx, Inc. | — | Biotechnology | Series B | $51.8M | $137.5M | 2009 |
| Alume Biosciences Inc | — | Biotechnology | Series A | $33.4M | $18.9M | 2022 |
| Sente Inc | — | Other Health Care | Series A | $20.6M | $171.2M | 2014 |
| Independa, Inc. | — | Other Health Care | Series A | $13.6M | $28.3M | 2017 |
| ProciseDX Inc. | — | Biotechnology | Series A | $9.0M | $317.2M | 2020 |
| MatriSys Bioscience, Inc. | — | Biotechnology | Series A | $8.4M | $113.7M | 2022 |
Magda Marquet at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Magda Marquet on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Wei Li | 1 | 7 |
| Kim Kamdar | 1 | 6 |
| Faheem Hasnain | 1 | 5 |
| John Wu | 1 | 4 |
| James Mackay | 1 | 4 |
| Kleanthis Xanthopoulos | 1 | 4 |
| Andrew Jackson | 1 | 4 |
| Jason Liu | 1 | 4 |
| David Nikodem | 1 | 4 |
| J. Matthew Mackowski | 1 | 4 |
| Philippe Schaison | 1 | 3 |
| Dan Bradbury | 1 | 3 |
| Jeffrey G. Black | 1 | 3 |
| Andrew Arno | 1 | 3 |
| Jean-Pierre Millon | 1 | 3 |
| James Schmidt | 1 | 3 |
| John Carrington | 1 | 2 |
| Brett Berman | 1 | 2 |
| Michael York | 1 | 2 |
| Deval A Lashkari | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.